Bolodeoku, John, Terry Gbaa, Katherine Morris, and Simon Whitehead. “Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and Evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/L LDL Cholesterol Target in a Secondary Care Lipid Clinic”. British Journal of Healthcare and Medical Research 10, no. 6 (December 17, 2023): 91–102. Accessed May 20, 2024. https://journals.scholarpublishing.org/index.php/JBEMi/article/view/15955.